ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Research Reagent/MCA-PRO-LEU-ALA-NVA-DAP(DNP)-ALA-ARG-NH2
C48H66N14O15
1079.1 g/mol
Research Reagent

MCA-PRO-LEU-ALA-NVA-DAP(DNP)-ALA-ARG-NH2

CAS256394-92-0
Category
Research Reagent
Compound Class
Peptide
Primary Use
Research Compound

This compound is a synthetic peptide-based research reagent designed for use as a fluorogenic protease substrate. Its structure incorporates multiple amino acid residues and a fluorogenic moiety, enabling fluorescence-based detection of specific protease activity in biochemical assays.

Fluorogenic protease substrate for biochemical assays

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing MCA-PRO-LEU-ALA-NVA-DAP(DNP)-ALA-ARG-NH2?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

ReferenceSame Category

Deoxyguanosine triphosphate

CAS2564-35-4

research compound

ReferenceSame Category

TEMPO

CAS2564-83-2

research compound

ReferenceSame Category

N-(2-((2-Acrylamido-5-methoxy-4-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)(methyl)amino)ethyl)-3-((2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)amino)-N,N-dimethyl-3-oxopropan-1-aminium

CAS2564638-97-5

research compound

ReferenceSame Category

1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide hydrochloride

CAS256499-19-1

research compound

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(2,4-dinitroanilino)-1-oxopropan-2-yl]amino]-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-1-[2-(7-methoxy-2-oxochromen-4-yl)acetyl]pyrrolidine-2-carboxamide

InChIKey

DYDYFAWKKWLFGJ-JSWDBWGRSA-N

SMILES

CC[C@@H](C(=O)N[C@@H](CNC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-])C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)CC3=CC(=O)OC4=C3C=CC(=C4)OC

Synonyms (3)

—

Sourcing MCA-PRO-LEU-ALA-NVA-DAP(DNP)-ALA-ARG-NH2?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→